ArticleBMC cancer2025

Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients.

Audrey Glory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.